Lilly brings Mounjaro to Spain, the slimming drug that competes with Ozempic

After the revolution it has brought, Mounjaro (tirzepatide), Lilly's innovative drug for treating type 2 diabetes or for weight control in people with obesity, is now available in Spain. This drug, for weekly subcutaneous administration, will be available starting next July 1 in Spanish pharmacies, always under medical prescription, with doses of 5 and 10 mg. This has been reported by the pharmacist, who points out that Mounjaro is the first and…